CrushSCI.com
71.1Average days
68Median days
23Fastest days
114Longest days
2002025 publications

Paper Review Records

All Paper Review Records

21 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

70 days

Cost-effectiveness analysis of pneumococcal vaccination of at-risk and high-risk adults aged 18–64 years in Switzerland using PCV21

Authors
Muloongo Simuzingili; Zinan Yi; Andrea Favre-Bulle; Thomas Mutschler; Eleana Tsoumani; Kwame Owusu-EduseiShow moreShow less
Affiliations
1. Merck & Co., Inc; 2. MSD Switzerland; 3. MSD GreeceShow moreShow less
Source PDF DOI Publisher page
114 days

Projected burden of bloodstream infections and the impact of molecular rapid diagnostic testing on costs and mortality in England and the United States (2025–2029): a population-level budget impact analysis

Authors
James K. Karichu; Mark Pennington; Kiera Lander; Tiffeny T. Smith; Adam ThornbergShow moreShow less
Affiliations
1. Roche Molecular Systems; 2. Source Health Economics; 3. Roche Diagnostics CorporationShow moreShow less
Source PDF DOI Publisher page
62 days

Societal and fiscal gains from HPV vaccination in Poland – return on investment from extending access to HPV vaccination

Authors
Rafal Jaworski; Nikolaos Kotsopoulos; Marcin Czech; Mark P. Connolly; Andrew Pavelyev; Alicja Wojcik; Ugne SabaleShow moreShow less
Affiliations
1. Market Access Department, MSD; 2. Global Market Access Solutions Sàrl; 3. University of Athens; 4. Pharmacoeconomic Department, Institute of Mother and Child; 5. University Groningen; 6. Health Economic and Decision Sciences, Merck & Co., Inc; 7. Value & Implementation Outcomes Research, MSD VilniusShow moreShow less
Source PDF DOI Publisher page
41 days

Cost-effectiveness analysis of elranatamab versus physician’s choice of treatment (non–BCMA-directed regimens) in patients with triple class exposed multiple myeloma in Japan

Authors
Akira Yuasa; Mitsuhiro Nagano; Yoichi Kamei; Kengo Hatsuyama; Hiroyuki Matsuda; Patrick Hlavacek; Marco DiBonaventura; Kenshi SuzukiShow moreShow less
Affiliations
1. Japan Access & Value, Pfizer Japan Inc; 2. Pfizer R&D Japan G.K; 3. Real World Evidence Solutions & HEOR, IQVIA Solutions Japan G.K; 4. HTA, Value & Evidence, Pfizer Inc; 5. Myeloma/AL Amyloid Unit, Japanese Red Cross Medical CenterShow moreShow less
Source PDF DOI Publisher page
42 days

Real-world healthcare resource utilization and cost burden of COVID-19 in commercially insured adults at high-risk of severe disease in the US: a retrospective database analysis

Authors
Tendai Mugwagwa; Benjamin A. Abramoff; Siddharth Karanth; Tram Nham; Ravi K. Goyal; Elizabeth Esterberg; Gurinder S. Sidhu; Alon Yehoshua; Ruth MokgokongShow moreShow less
Affiliations
1. Pfizer Ltd; 2. University of Pennsylvania; 3. RTI Health Solutions; 4. Pfizer IncShow moreShow less
Source PDF DOI Publisher page
53 days

Cost-effectiveness analysis of Cardioform vs. Amplatzer: concerns regarding methodological transparency and interpretation of clinical results

Authors
David W. Hutton; Anne M. Ryschon; Scott Goates; Jan B. Pietzsch; Lars SøndergaardShow moreShow less
Affiliations
1. Department of Health Management and Policy, University of Michigan; 2. Wing Tech Inc; 3. Global Data Science and Analysis; 4. Abbott, CA, USAShow moreShow less
Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.